Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| StemCells, Inc. (NASDAQ: TEM) | Delayed: 65.53 -2.23 (3.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.76 | 52 Week High | $0.45 | |||
| Open | $66.10 | 52 Week Low | $0.37 | |||
| Day High | $68.29 | P/E | N/A | |||
| Day Low | $65.05 | EPS | $-0.31 | |||
| Volume | 903,899 | |||||
